Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: Results from GROINSS-V, a multicentre observational study

The Lancet Oncology

Volumn 11, Issue 7, 2010, Pages 646-652

  Oonk, M H ^a   van Hemel, B M ^a   Hollema, H ^a   de Hullu, J A ^b   Ansink, A C ^c   Vergote, I ^d   Verheijen, R H ^e   Maggioni, A ^f   Gaarenstroom, K N ^g   Baldwin, P J ^h   van Dorst, E B ⁱ   van der Velden, J ^j   Hermans, R H ^k   van der Putten, H W ^l   Drouin, P ^m   Runnebaum, I B ⁿ   Sluiter, W J ^a   van der Zee, A G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h ADDENBROOKE S HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^j ACADEMIC MEDICAL CENTER   (Netherlands)

^k MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^l CATHARINA HOSPITAL   (Netherlands)

^m CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁿ FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; OBSERVATIONAL STUDY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR VOLUME; VULVA CANCER;

AGED; DISEASE-FREE SURVIVAL; FEMALE; GROIN; HUMANS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS; VULVAR NEOPLASMS;

EID: 77954035099     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(10)70104-2     Document Type: Article

References (23)

1. Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008, 26:884-889.
2. Gietema HA, Vuylsteke RJ, De Jonge IA, et al. Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2004, 57:618-620.
3. Weaver DL, Le UP, Dupuis SL, et al. Metastasis detection in sentinel lymph nodes: comparison of a limited widely spaced (NSABP protocol B-32) and a comprehensive narrowly spaced paraffin block sectioning strategy. Am J Surg Pathol 2009, 33:1583-1589.
4. De Hullu JA, Hollema H, Piers DA, et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000, 18:2811-2816.
5. Vidal-Sicart S, Puig-Tintoré LM, Lejárcequi JA, et al. Validation and application of the sentinel lymph node concept in malignant vulvar tumours. Eur J Nucl Med Mol Imaging 2007, 34:384-391.
6. TNM: classification of malignant tumours 2002, Wiley, New York. 6th edn. L.H. Sobin, C.H. Wittekind (Eds.).
7. Fleming FJ, Kavanagh D, Crotty TB, et al. Factors affecting metastases to non-sentinel lymph nodes in breast cancer. J Clin Pathol 2004, 57:73-76.
8. Van Deurzen CH, van Hillegersberg R, Hobbelink MG, et al. Predictive value of tumor load in breast cancer sentinel lymph nodes for second echelon lymph node metastases. Cell Oncol 2007, 29:497-505.
9. Van Deurzen CH, de Boer M, Monninkhof EM, et al. Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst 2008, 100:1574-1580.
10. Van Akkooi AC, Nowecki ZI, Voit C, et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann Surg 2008, 248:949-955.
11. Homesley HD, Bundy BN, Sedlis A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 1991, 164:997-1003.
12. Burger MP, Hollema H, Emanuels AG, et al. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol 1995, 57:327-334.
13. Beller U, Quinn MA, Benedet JL, et al. Carcinoma of the vulva. FIGO 6th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006, 95:S7-S27.
14. De Boer M, van Deurzen CHM, van Dijck JAAM, et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 2009, 361:653-663.
15. Reed J, Rosman M, Verbanac KM, et al. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Cancer Sentinel Node Multicenter Study. J Am Coll Surg 2009, 208:333-340.
16. Hansen NM, Grube B, Ye X, Turner RR, et al. Impact of micrometastases in the sentinel node of patients with invasive breast cancer. J Clin Oncol 2009, 27:4640-4641.
17. Kiluk JV, Ly QP, Meade T, et al. Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up. Ann Surg Oncol 2009, published online Sept 24. 10.1245/s10434-009-0704-1.
18. Newman LA, Hunt KK, Buchholz T, et al. Presentation, management and outcome of axillary recurrence from breast cancer. Am J Surg 2000, 180:252-256.
19. Origoni M, Sideri M, Garsia S, et al. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol Oncol 1992, 45:313-316.
20. Paladini D, Cross P, Lopes A, et al. Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva. Cancer 1994, 74:2399-2402.
21. Knopp S, Holm R, Tropé C, et al. Occult lymph node metastases in early stage vulvar carcinoma patients. Gynecol Oncol 2005, 99:383-387.
22. Narayansingh GV, Miller ID, Sharma M, et al. The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva. Br J Cancer 2005, 92:222-224.
23. Roberts CA, Beitsch PD, Litz CE, et al. Interpretive disparity among pathologists in breast sentinel lymph node evaluation. Am J Surg 2003, 186:324-329.